S. Bott

854 total citations
11 papers, 590 citations indexed

About

S. Bott is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Bott has authored 11 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Bott's work include Diabetes Management and Research (8 papers), Diabetes Treatment and Management (5 papers) and Pancreatic function and diabetes (4 papers). S. Bott is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Treatment and Management (5 papers) and Pancreatic function and diabetes (4 papers). S. Bott collaborates with scholars based in Germany, United States and Denmark. S. Bott's co-authors include Tim Heise, U. Bott, Michael Berger, Ingrid Mühlhauser, Lutz Heinemann, Klaus Rave, R.M. McDevitt, W. A. Coward, Andrew M. Prentice and Leslie J. C. Bluck and has published in prestigious journals such as American Journal of Clinical Nutrition, Diabetes Care and Diabetologia.

In The Last Decade

S. Bott

10 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Bott Germany 9 452 167 121 120 106 11 590
Cecile C. Balagtas United States 6 208 0.5× 112 0.7× 249 2.1× 46 0.4× 46 0.4× 7 419
Ming‐Chun Kuo Taiwan 13 195 0.4× 114 0.7× 52 0.4× 25 0.2× 66 0.6× 28 460
H J Cüppers Germany 9 275 0.6× 112 0.7× 19 0.2× 55 0.5× 80 0.8× 14 411
K Maekawa Japan 7 118 0.3× 53 0.3× 96 0.8× 31 0.3× 45 0.4× 20 431
P A Jenkins United Kingdom 12 121 0.3× 60 0.4× 62 0.5× 64 0.5× 85 0.8× 27 358
Andrés Palacio Colombia 7 690 1.5× 110 0.7× 27 0.2× 223 1.9× 20 0.2× 18 784
Yasuhisa MATSUSHIMA Japan 7 152 0.3× 142 0.9× 15 0.1× 64 0.5× 106 1.0× 13 432
Juana A. Flores-Le-Roux Spain 8 233 0.5× 167 1.0× 19 0.2× 113 0.9× 90 0.8× 12 402
Reuben B. Young United States 12 89 0.2× 81 0.5× 59 0.5× 85 0.7× 25 0.2× 16 347
Jacqueline R. Curtis Canada 7 217 0.5× 104 0.6× 21 0.2× 152 1.3× 44 0.4× 8 332

Countries citing papers authored by S. Bott

Since Specialization
Citations

This map shows the geographic impact of S. Bott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bott more than expected).

Fields of papers citing papers by S. Bott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bott. The network helps show where S. Bott may publish in the future.

Co-authorship network of co-authors of S. Bott

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bott. A scholar is included among the top collaborators of S. Bott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bott. S. Bott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bott, S., Lisbeth V. Jacobsen, Lars Endahl, et al.. (2006). Insulin detemir under steady‐state conditions: no accumulation and constant metabolic effect over time with twice daily administration in subjects with Type 1 diabetes. Diabetic Medicine. 23(5). 522–528. 31 indexed citations
2.
Bott, S., Yanal Shafagoj, P. T. Sawicki, & Tim Heise. (2005). Impact of Smoking on the Metabolic Action of Subcutaneous Regular Insulin in Type 2 Diabetic Patients. Hormone and Metabolic Research. 37(7). 445–449. 13 indexed citations
3.
Bott, S., et al.. (2005). The Pharmacokinetic and Pharmacodynamic Properties of Biphasic Insulin Aspart 70 (BIAsp 70) are Significantly Different from those of Biphasic Insulin Aspart 30 (BIAsp 30). Experimental and Clinical Endocrinology & Diabetes. 113(9). 545–550. 6 indexed citations
4.
Heise, Tim, et al.. (2005). The Effect of Insulin Antibodies on the Metabolic Action of Inhaled and Subcutaneous Insulin. Diabetes Care. 28(9). 2161–2169. 63 indexed citations
5.
Rave, Klaus, S. Bott, Lutz Heinemann, et al.. (2005). Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin. Diabetes Care. 28(5). 1077–1082. 122 indexed citations
6.
Kapitza, Christoph, Tim Heise, Robert Fishman, et al.. (2004). Impact of Particle Size and Aerosolization Time on the Metabolic Effect of an Inhaled Insulin Aerosol. Diabetes Technology & Therapeutics. 6(2). 119–127. 10 indexed citations
7.
Heise, Tim, et al.. (2002). No evidence for accumulation of insulin glargine (LANTUS®): a multiple injection study in patients with Type 1 diabetes. Diabetic Medicine. 19(6). 490–495. 48 indexed citations
8.
McDevitt, R.M., et al.. (2001). De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women. American Journal of Clinical Nutrition. 74(6). 737–746. 130 indexed citations
10.
Heise, Tim, et al.. (2000). No evidence for accumulation of HOE901 after multiple injections in type I diabetic patients. 1. 196. 2 indexed citations
11.
Bott, S., U. Bott, Michael Berger, & Ingrid Mühlhauser. (1997). Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia. 40(8). 926–932. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026